US loss of exclusivity · Oncology
Tagrisso
AstraZeneca
2032
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$7.3B
Date basis
Patent-expiry estimate
US generics
No US filing found
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Tagrisso timeline →